[HTML][HTML] Immunopathology of Hyperinflammation in COVID-19

JN Gustine, D Jones - The American journal of pathology, 2021 - Elsevier
The rapid spread of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome–coronavirus 2 (SARS-CoV-2), has resulted in an unprecedented …

Patients with COVID-19: in the dark-NETs of neutrophils

M Ackermann, HJ Anders, R Bilyy, GL Bowlin… - Cell Death & …, 2021 - nature.com
SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs,
occasionally causing death. Until effective vaccines are developed to curb the pandemic, it …

Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19

N Rosenthal, Z Cao, J Gundrum, J Sianis… - JAMA network …, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) has infected more than 8.1 million US
residents and killed more than 221 000. There is a dearth of research on epidemiology and …

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)

A Bhimraj, RL Morgan, AH Shumaker… - Clinical infectious …, 2024 - academic.oup.com
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis

G Corona, A Pizzocaro, W Vena, G Rastrelli… - Reviews in Endocrine …, 2021 - Springer
The presence of SARS-CoV-2 was officially documented in Europe at the end of February
2020. Despite many observations, the real impact of COVID-19 in the European Union (EU) …

[HTML][HTML] Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

MAB Lucien, MF Canarie, PE Kilgore… - International journal of …, 2021 - Elsevier
The dissemination of COVID-19 around the globe has been followed by an increased
consumption of antibiotics. This is related to the concern for bacterial superinfection in …

Azithromycin in the treatment of COVID-19: a review

D Echeverría-Esnal, C Martin-Ontiyuelo… - Expert review of anti …, 2021 - Taylor & Francis
Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …

Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis

T Fiolet, A Guihur, ME Rebeaud, M Mulot… - Clinical microbiology …, 2021 - Elsevier
Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …

A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for …

CR Triggle, D Bansal, H Ding, MM Islam… - Frontiers in …, 2021 - frontiersin.org
COVID-19 emerged from China in December 2019 and during 2020 spread to every
continent including Antarctica. The coronavirus, SARS-CoV-2, has been identified as the …

One year update on the COVID-19 pandemic: Where are we now?

SK Mishra, T Tripathi - Acta tropica, 2021 - Elsevier
We are living through an unprecedented crisis with the rapid spread of the new coronavirus
disease (COVID-19) worldwide within a short time. The timely availability of thousands of …